|
| The authors showed that the gut microbiome downregulated programmed death ligand (PD-L) 2 expression and its binding partner repulsive guidance molecule b (RGMb) to promote anti-tumor immunity, and identified bacterial species that mediated this effect. [Nature] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers analyzed mononuclear phagocytes in small intestinal Peyer’s patches, the primary inductive site of intestinal immunity. [Immunity] |
|
|
|
| To elucidate tumoral Treg cell ‘connectivity’ to diverse tumor-supporting accessory cell types, scientists explored immediate early changes in their single-cell transcriptomes upon punctual Treg cell depletion in experimental lung cancer and injury-induced inflammation. [Nature Immunology] |
|
|
|
| Conditional deletion of Bcl11b resulted in increased numbers of intestinal intestinal-resident memory CD8+ T cells and their precursors, as well as decreased splenic effector and circulating memory cells and precursors. [Science Immunology] |
|
|
|
| SEL1L or HRD1 deficiency in macrophages specifically amplified stimulator of interferon genes (STING) signaling and immunity against viral infection and tumor growth. [Nature Cell Biology] |
|
|
|
| Scientists characterized breast and lung cancer-induced bone marrow ecosystem shifts pre- and post-tumor removal. Remote tumors progressively led to osteoprogenitor expansion, hematopoietic stem cell dislocation, and CD41− granulocyte-monocyte progenitor aggregation. [Cell Stem Cell] |
|
|
|
| Tumor cells induced immune-responsive gene 1 (IRG1) expression in macrophages by activating NF-κB pathway, and itaconic acids produced by aconitate decarboxylase inhibited TET DNA dioxygenases to dampen the expression of inflammatory genes and the infiltration of CD8+ T cells into tumor sites. [Science Advances] |
|
|
|
| Investigators utilized a proteomics-based approach to assess phosphorylation changes in primary murine macrophages following stimulator of interferon genes (STING) activation. [EMBO Journal] |
|
|
|
| Researchers revealed that the P38 regulated/activated protein kinase (PRAK)-NF-E2-related factor 2 (NRF2) axis was essential for maintaining the intracellular redox homeostasis of T helper 17 (Th17) cells, thereby promoting Th17 cell differentiation and antitumor effects. [Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
|
| The authors detail the progression of immune system and microbiota maturation in early life, highlight the mechanistic links between microbes and the immune system, and summarize the role of early-life host–microorganism interactions in allergic disease development. [Nature Reviews Immunology] |
|
|
|
| Scientists summarize the newly emerging role of viral and host-derived RNA polymerase III transcripts in immunity, and also highlight recent advances in understanding how mammalian cellsA prevent unwanted immune activation by these RNAs to maintain homeostasis. [Trends In Immunology] |
|
|
|
|
| Immatics N.V. announced that Bristol Myers Squibb has exercised its option and entered into an exclusive worldwide license for the first T cell receptor engineered T cell therapy candidate from their ongoing collaboration. [Immatics N.V.] |
|
|
|
|
| June 2 – 6, 2023 Chicago, Illinois, United States |
|
|
|
|
|
| California Institute of Technology – Pasadena, California, United States |
|
|
|
| University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
| Novartis – Cambridge, Massachusetts, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Rutgers New Jersey Medical School – Newark, New Jersey, United States |
|
|
|
|